A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study
Michael Davidson(Idera Pharmaceuticals (United States)), Judith Johnson(Idera Pharmaceuticals (United States)), Michael W. Rooney(Radiant Research (United States)), Michael Kyle(Radiant Research (United States)), Douglas Kling(Idera Pharmaceuticals (United States))
Cited by 185
Abstract
Related Papers
No related papers found
Powered by citation graph analysis